Physician profile
Jillian Maloney
NPI 1124339684
$3,080.65
in general payments reported to CMS, 2019-2025
21 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $1,228 · 2021: $317 · 2022: $352 · 2023: $212 · 2024: $271 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,749.62 | 2019-2022 | |
| Medtronic, INC. | $477.87 | 2024-2025 | Inceptiv, Intellis Adaptivestim |
| Nevro Corp. | $305.84 | 2022-2024 | Senza |
| Saluda Medical Americas, INC. | $78.57 | 2022 | |
| Boston Scientific Corporation | $77.99 | 2024-2025 | Wavewriter Alpha Prime 16, Intracept |
| Collegium Pharmaceutical, INC. | $57.70 | 2019 | |
| Allergan, INC. | $53.88 | 2019 | |
| Biotronik Nro, INC. | $46.13 | 2025 | Prospera |
| Biodelivery Sciences International, INC. | $38.49 | 2019 | |
| Avanos Medical | $29.90 | 2023 | On-Q* Pump and Accessories |
| Globus Medical, INC. | $22.84 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.05 | 2019 | |
| Amgen INC. | $16.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.65 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.55 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $14.34 | 2019 | |
| Lilly USA, LLC | $13.73 | 2019 | |
| Assertio Therapeutics, INC. | $13.22 | 2019 | |
| Pfizer INC. | $12.36 | 2019 | |
| Zyla Life Sciences, INC. | $11.77 | 2019 | |
| Daiichi Sankyo INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Maloney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.